Trial Profile
Clinical Trials Insight: 700024270
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 02 Jul 2007
Price :
$35
*
At a glance
- Drugs Cefalexin (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- Sponsors MiddleBrook Pharmaceuticals
- 02 Jul 2007 New trial record.